ASH 2018 | Studying the genetics of CLL to prevent Richter’s transformation

VJHemOnc is committed to improving our service to you

Stephan Stilgenbauer

Stephan Stilgenbauer, MD, of the University of Ulm, Ulm, Germany, speaks at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. He discusses how the genetics of chronic lymphocytic leukemia (CLL) impacts outcome in patients, with particular reference to IGHV, TP53 and MYC mutations. He talks about strategies to prevent Richter’s transformation using existing and novel treatments.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter